RS

Rajesh Shankarlal Jaiswal

Active Director Director DIN 10294426
DIN 10294426 First appointment Aug 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Shankarlal Jaiswal

Data last updated:

Rajesh Shankarlal Jaiswal is a Director at Neozene Laboratories Private Limited (since 2023). The company operates in Healthcare.

DIN 10294426
Primary Designation Director
Industry Healthcare
First Appointment 25 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neozene Laboratories Private Limited U86905MH2023PTC409382
Director25 Aug 20232023Active

Board colleagues of Rajesh Shankarlal Jaiswal

Directorship timeline

Open interactive timeline →
Neozene Laboratories Private Limited
Premium access

Shareholding and investment profile for Rajesh Shankarlal Jaiswal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Shankarlal Jaiswal

Rajesh Shankarlal Jaiswal currently holds 1 directorship: Neozene Laboratories Private Limited (Director, since 25 Aug 2023).

Rajesh Shankarlal Jaiswal was first appointed on 25 Aug 2023 as Director at Neozene Laboratories Private Limited.

The current boards of Rajesh Shankarlal Jaiswal's companies include Amit Janardan Sharma (Neozene Laboratories Private Limited), Zahid Hussain Shaikh (Neozene Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available